Drug treatments for covid-19: living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum… - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar

G Giustino, SP Pinney, A Lala, VY Reddy… - Journal of the American …, 2020 - jacc.org
The cardiovascular system is affected broadly by severe acute respiratory syndrome
coronavirus 2 infection. Both direct viral infection and indirect injury resulting from …

Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis

R Baral, V Tsampasian, M Debski, B Moran… - JAMA network …, 2021 - jamanetwork.com
Importance The chronic receipt of angiotensin-converting enzyme inhibitors (ACEIs) and
angiotensin receptor blockers (ARBs) has been assumed to exacerbate complications …

Prophylaxis against covid-19: living systematic review and network meta-analysis

JJ Bartoszko, RAC Siemieniuk, E Kum, A Qasim… - Bmj, 2021 - bmj.com
Updates This is the second version (first update) of the living systematic review, replacing
the previous version (available as a data supplement). When citing this paper please …

Lower incidence of COVID-19 at high altitude: facts and confounders

M Pun, R Turner, G Strapazzon, H Brugger… - … Altitude Medicine & …, 2020 - liebertpub.com
Pun, Matiram, Rachel Turner, Giacomo Strapazzon, Hermann Brugger, and Erik R.
Swenson. Lower incidence of COVID-19 at high altitude: Facts and confounders. High Alt …

Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics

SH Rezkalla, RA Kloner - Trends in cardiovascular medicine, 2021 - Elsevier
Myocarditis is common during viral infection with cases described as early as the influenza
pandemic of 1917, and the current COVID-19 pandemic is no exception. The hallmark is …

Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury

R Sarzani, F Giulietti, C Di Pentima… - … of Physiology-Lung …, 2020 - journals.physiology.org
A dysregulation of the renin-angiotensin system (RAS) has been involved in the genesis of
lung injury and acute respiratory distress syndrome from different causes, including several …

A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor

M Oz, DE Lorke, N Kabbani - Pharmacology & therapeutics, 2021 - Elsevier
The recent emergence of coronavirus disease-2019 (COVID-19) as a global pandemic has
prompted scientists to address an urgent need for defining mechanisms of disease …

Renin‐angiotensin aldosterone system inhibitors and COVID‐19: a systematic review and meta‐analysis revealing critical bias across a body of observational …

J Loader, FC Taylor, E Lampa… - Journal of the American …, 2022 - Am Heart Assoc
Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies,
observational in design, appear to use biased methods that can distort the interaction …

[HTML][HTML] Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis

SS Hasan, CS Kow, MA Hadi, STR Zaidi… - American Journal of …, 2020 - Springer
Introduction The use of renin-angiotensin system (RAS) inhibitors, including angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was …